Matches in SemOpenAlex for { <https://semopenalex.org/work/W3125518085> ?p ?o ?g. }
- W3125518085 endingPage "332" @default.
- W3125518085 startingPage "332" @default.
- W3125518085 abstract "Silver nanoparticles (AgNPs) are the most widely studied antimicrobial nanomaterials. However, their use in biomedicine is currently limited due to the availability of data that prove the nanosilver toxicity associated primarily with oxidative stress development in mammalian cells. The surface modification of AgNPs is a potent technique of improvement of their biocompatibility. The synthetic or natural compounds that combine zero or low toxicity towards human and animal organisms with inherent antimicrobial properties are the most promising stabilizing agents, their use would also minimize the risks of microorganisms developing resistance to silver-based materials. We used a simple technique to obtain 30–60 nm AgNPs stabilized with benzyldimethyl[3-myristoylamine)-propyl]ammonium chloride monohydrate (BAC)—a well-known active ingredient of many antibacterial drugs. The objective of the study was to assess the AgNPs-BAC entero- and hepatotoxicity to CBF1 mice upon enteral administration. The animals were exposed to 0.8–7.5 mg/kg doses of AgNPs-BAC in the acute and to 0.05–2.25 mg/kg doses of AgNPs-BAC in the subacute experiments. No significant entero- and hepatotoxic effects following a single exposure to doses smaller than 4 mg/kg were detected. Repeated exposure to the doses of AgNPs-BAC below 0.45 mg/kg and to the doses of BAC below 0.5 mg/kg upon enteral administration also led to no adverse effects. During the acute experiment, the higher AgNPs-BAC dose resulted in increased quantities of aminotransferases and urea, as well as the albumin-globulin ratio shift, which are indicative of inflammatory processes. Besides, the relative mass of the liver of mice was smaller compared to the control. During the subacute experiment, the groups treated with the 0.25–2.25 mg/kg dose of AgNPs-BAC had a lower weight gain rate compared to the control, while the groups treated with the 2.25 mg/kg dose of AgNPs-BAC showed statistically significant variations in the blood serum transaminases activity, which indicated hepatosis. It should be noted that the spleen and liver of the animals from the groups treated with the 0.45 and 2.25 mg/kg dose of AgNPs-BAC were more than two times smaller compared to the control. In the intestines of some animals from the group treated with the 2.25 mg/kg dose of AgNPs-BAC small areas of hyperemia and enlarged Peyer’s patches were observed. Histological examination confirmed the initial stages of the liver and intestinal wall inflammation." @default.
- W3125518085 created "2021-02-01" @default.
- W3125518085 creator A5004096641 @default.
- W3125518085 creator A5032007531 @default.
- W3125518085 creator A5055770459 @default.
- W3125518085 creator A5057422600 @default.
- W3125518085 creator A5071889898 @default.
- W3125518085 creator A5084128033 @default.
- W3125518085 creator A5085906294 @default.
- W3125518085 creator A5089103108 @default.
- W3125518085 date "2021-01-27" @default.
- W3125518085 modified "2023-10-17" @default.
- W3125518085 title "In Vivo Study of Entero- and Hepatotoxicity of Silver Nanoparticles Stabilized with Benzyldimethyl-[3-myristoylamine)-propyl]ammonium Chloride (Miramistin) to CBF1 Mice upon Enteral Administration" @default.
- W3125518085 cites W1948500015 @default.
- W3125518085 cites W1966293661 @default.
- W3125518085 cites W1987386891 @default.
- W3125518085 cites W1998808067 @default.
- W3125518085 cites W1998927231 @default.
- W3125518085 cites W2009766065 @default.
- W3125518085 cites W2012192365 @default.
- W3125518085 cites W2016508077 @default.
- W3125518085 cites W2025808947 @default.
- W3125518085 cites W2026225585 @default.
- W3125518085 cites W2035652467 @default.
- W3125518085 cites W2036098906 @default.
- W3125518085 cites W2039326778 @default.
- W3125518085 cites W2042795875 @default.
- W3125518085 cites W2045952298 @default.
- W3125518085 cites W2052138249 @default.
- W3125518085 cites W2055161910 @default.
- W3125518085 cites W2065344008 @default.
- W3125518085 cites W2070503366 @default.
- W3125518085 cites W2078287490 @default.
- W3125518085 cites W2088661392 @default.
- W3125518085 cites W2100557588 @default.
- W3125518085 cites W2103030230 @default.
- W3125518085 cites W2107061989 @default.
- W3125518085 cites W2111836708 @default.
- W3125518085 cites W2118103693 @default.
- W3125518085 cites W2132714700 @default.
- W3125518085 cites W2139652646 @default.
- W3125518085 cites W2141237239 @default.
- W3125518085 cites W2146385374 @default.
- W3125518085 cites W2146482929 @default.
- W3125518085 cites W2151167710 @default.
- W3125518085 cites W2168743262 @default.
- W3125518085 cites W2274054439 @default.
- W3125518085 cites W2292739085 @default.
- W3125518085 cites W2299686924 @default.
- W3125518085 cites W2336991720 @default.
- W3125518085 cites W2463836225 @default.
- W3125518085 cites W2467200611 @default.
- W3125518085 cites W2491864168 @default.
- W3125518085 cites W2509634871 @default.
- W3125518085 cites W2535275241 @default.
- W3125518085 cites W2559705562 @default.
- W3125518085 cites W2753419172 @default.
- W3125518085 cites W2754680533 @default.
- W3125518085 cites W2773377755 @default.
- W3125518085 cites W2794692906 @default.
- W3125518085 cites W2803379230 @default.
- W3125518085 cites W2891025978 @default.
- W3125518085 cites W2908477284 @default.
- W3125518085 cites W2912343337 @default.
- W3125518085 cites W2914872899 @default.
- W3125518085 cites W2936864325 @default.
- W3125518085 cites W2952193801 @default.
- W3125518085 cites W2955502700 @default.
- W3125518085 cites W2987668121 @default.
- W3125518085 cites W2990078139 @default.
- W3125518085 cites W2999199485 @default.
- W3125518085 cites W3006340673 @default.
- W3125518085 cites W3011851677 @default.
- W3125518085 cites W3012828684 @default.
- W3125518085 cites W3017069776 @default.
- W3125518085 cites W3020623782 @default.
- W3125518085 cites W3023994700 @default.
- W3125518085 cites W3026260242 @default.
- W3125518085 cites W3043884858 @default.
- W3125518085 cites W4296550403 @default.
- W3125518085 doi "https://doi.org/10.3390/nano11020332" @default.
- W3125518085 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7911341" @default.
- W3125518085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33513948" @default.
- W3125518085 hasPublicationYear "2021" @default.
- W3125518085 type Work @default.
- W3125518085 sameAs 3125518085 @default.
- W3125518085 citedByCount "5" @default.
- W3125518085 countsByYear W31255180852021 @default.
- W3125518085 countsByYear W31255180852022 @default.
- W3125518085 countsByYear W31255180852023 @default.
- W3125518085 crossrefType "journal-article" @default.
- W3125518085 hasAuthorship W3125518085A5004096641 @default.
- W3125518085 hasAuthorship W3125518085A5032007531 @default.
- W3125518085 hasAuthorship W3125518085A5055770459 @default.
- W3125518085 hasAuthorship W3125518085A5057422600 @default.
- W3125518085 hasAuthorship W3125518085A5071889898 @default.
- W3125518085 hasAuthorship W3125518085A5084128033 @default.
- W3125518085 hasAuthorship W3125518085A5085906294 @default.